Cases 1 - 4 of 4
Cesar Castillo, Inc. v. Ranbaxy Inc. et al
as 1:2019cv10357
Defendant:
Ranbaxy U.S.A. Inc., Ranbaxy Inc., RANBAXY LABORATORIES, LTD. and others
Plaintiff:
Cesar Castillo, Inc.
Cause Of Action: 18 U.S.C. § 1962
In Re: Ranbaxy Generic Drug Application Antitrust Litigation
as 1:2019md02878
In Re:
Ranbaxy Generic Drug Application Antitrust Litigation
Plaintiff:
Meijer, Inc., Meijer Distribution, Inc., Cesar Castillo, Inc. and others
Defendant:
Ranbaxy Laboratories Limited, Sun Pharmaceutical Industries Limited, Ranbaxy, Inc. and others
Consolidated Plaintiff:
United Food and Commercial Workers Health and Welfare Fund of Northern Pennsylvania and Louisiana Health Services and Indemnity Company d/b/a Blue Cross and Blue Shield of Louisiana
Respondent:
Prinston Pharmaceutical Inc.
Interested Party:
Novartis Pharmaceuticals Corporation and Astrazeneca Pharmaceuticals L.P.
Not Classified By Court:
Winifred Weitsen
Cause Of Action: 18 U.S.C. § 1962 Racketeering (RICO) Act
Cesar Castillo, Inc. v. Sanofi, U.S. et al
as 1:2017cv10042
Plaintiff:
Cesar Castillo, Inc.
Defendant:
Sanofi, U.S. and Sanofi GmbH
Cause Of Action: 15 U.S.C. § 1
In re Lantus Direct Purchaser Antitrust Litigation
as 1:2016cv12652
Defendant:
Sanofi GmbH, Sanofi-Aventis U.S., LLC and Sanofi-Aventis Puerto Rico, Inc.
Plaintiff:
FWK Holdings LLC, Meijer, Inc. and Meijer Distribution, Inc.
Consolidated Plaintiff:
Cesar Castillo, LLC and Cesar Castillo, Inc
Intervenor Plaintiff:
RDC Liquidating Trust, by and through its trustee, Advisory Trust Group LLC, MLI Rx LLC, Burlington Drug Company Inc. and others
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
